Related Experiment Videos

Diva/Boo is a negative regulator of cell death in human glioma cells

U Naumann1, S Weit, J Wischhusen

  • 1Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Tübingen, School of Medicine, Hoppe-Seyler-Str. 3, D-72076 Tübingen, Germany.

FEBS Letters
|September 15, 2001
PubMed

Insights

Diva, a Bcl-2 family protein, promotes glioma cell cycle exit and inhibits apoptosis. It interferes with apoptotic signaling, impacting the apoptosome and apoptosis activating factor-1 (APAF-1) pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Bcl-2 protein family regulates apoptosis.
  • Diva/Boo is a Bcl-2 family member with conflicting reports on its apoptotic role.
  • Glioma is a common type of brain tumor.

Purpose of the Study:

  • To investigate the role of Diva in human glioma cells.
  • To elucidate the mechanism of Diva's action in apoptosis.
  • To determine Diva's effect on cell cycle regulation.

Main Methods:

  • Cell culture of human glioma cells.
  • Induction of apoptosis using CD95 ligand and chemotherapeutic drugs.
  • Analysis of apoptotic signaling pathways, including cytochrome c release and caspase activation.
  • Assessment of cell cycle progression.

Main Results:

  • Diva promotes cell cycle exit in glioma cells under serum deprivation.
  • Diva inhibits apoptosis induced by CD95 ligand and chemotherapy.
  • Diva acts downstream of cytochrome c release but upstream of caspase activation.
  • Diva interferes with the mitochondrial amplification step involving the apoptosome and apoptosis activating factor-1 (APAF-1).

Conclusions:

  • Diva functions as a pro-survival protein in human glioma cells.
  • Diva's anti-apoptotic activity is mediated by interference with the apoptosome formation.
  • Diva plays a role in regulating cell fate decisions in glioma.

Related Concept Videos